Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: A retrospective analysis of administrative claims databases

Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: A retrospective analysis of administrative claims databases

Abstract   Introduction There are a paucity of real-world data examining effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) and warfarin in nonvalvular atrial fibrillation (NVAF) patients with prior bleeding. Methods This...

Contemporary Clinical and Economic Outcomes Among Oral Anticoagulant Treated and Untreated Elderly Patients With Atrial Fibrillation: Insights from the United States Medicare Database

Abstract Background: Oral anticoagulants (OACs) mitigate the risk of stroke in atrial fibrillation (AF) patients. Objective: Elderly AF patients who were treated with OACs (apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin) were compared against AF patients who...